Focus Feature: New insights into opioid tapering and risk of overdose
After the Centers for Disease Control and Prevention issued opioid prescribing guidelines in 2016, Kaiser Permanente was among the first health systems to implement programs for safer opioid tapering. Against this backdrop, a new Kaiser Permanente study showed that of patients with long-term high-dose opioid use, those who gradually reduced their dose within 3 months had a lower risk of overdose within a year than those who did not reduce their dose.
R&E News and Features
Q&A with Dr. Maheen Humayun, one of our new postdocs
From September 15 to 19, we celebrate National Postdoc Appreciation Week. Among our newest postdoctoral fellows is Maheen Humayun, PhD, MPH, who previously served as an HIV Cluster Detection and Response Fellow at the Centers for Disease Control and Prevention.
COVID-19 vaccine not linked to tinnitus
New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. The study was published this summer in Vaccine.
Fewer breast cancer patients received imaging follow-up after COVID-19 hit
Fewer breast cancer survivors received recommended annual breast cancer imaging in the time after the COVID-19 pandemic compared to before the pandemic.
Finding factors that could help patients achieve remission from Type 2 diabetes
New Kaiser Permanente study sheds light on the patients with Type 2 diabetes who are most likely to control their disease with only diet and exercise.
In the News
Pancreatic cancer cases increase in first 3 years of glycemic evidence of diabetes
Oncology Nurse AdvisorSeptember 2, 2025ASRS 2025: Racial and ethnic disparities in retinoblastoma treatment options
Ophthalmology TimesAugust 23, 2025
Five questions...
for Dr. Talar Habeshian
As we celebrate the 2025 National Postdoc Appreciation Week, let us introduce you to our newest postdoc, Talar Habeshian, PhD, MPH! She was appointed as a postdoctoral research fellow in the Division of Epidemiologic Research in August. She will focus on cancer research.